SEARCH

SEARCH BY CITATION

References

  • 1
    Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol. 1999; 17: 1720-1726.
  • 2
    Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002; 347: 567-575.
  • 3
    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227-1232.
  • 4
    Alkhatib W, Connor C, Fang F. Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg. 2007; 194: 856-858; discussion 858-859.
  • 5
    Chagpar AB, Scoggins CR, Martin RC II, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg. 2006; 192: 882-887.
  • 6
    Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg. 2001; 182: 316-320.
  • 7
    Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat. 2005; 91: 113-119.
  • 8
    Callejo IP, Brito JA, Bivar JW, et al. Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transl Oncol. 2005; 7: 18-22.
  • 9
    Carmon M, Olsha O, Schecter WP, et al. The “Sentinel Chain”: a new concept for prediction of axillary node status in breast cancer patients. Breast Cancer Res Treat. 2006; 97: 323-328.
  • 10
    Changsri C, Prakash S, Sandweiss L, Bose S. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J. 2004; 10: 392-397.
  • 11
    Cho J, Han W, Lee JW, et al. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol. 2008; 15: 2278-2286.
  • 12
    Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005; 190: 543-550.
  • 13
    Fleming FJ, Kavanagh D, Crotty TB, et al. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol. 2004; 57: 73-76.
  • 14
    Goyal A, Newcombe RG, Chhabra A, Mansel RE. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006; 99: 203-208.
  • 15
    Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg. 2001; 136: 688-692.
  • 16
    Kohrt HE, Olshen RA, Bermas HR, et al. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008; 8: 66.
  • 17
    Nos C, Harding-MacKean C, Freneaux P, et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg. 2003; 90: 1354-1360.
  • 18
    Ozmen V, Karanlik H, Cabioglu N, et al. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat. 2006; 95: 1-6.
  • 19
    Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg. 2008; 95: 302-309.
  • 20
    Sachdev U, Murphy K, Derzie A, Jaffer S, Bleiweiss IJ, Brower S. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg. 2002; 183: 213-217.
  • 21
    Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001; 25: 767-772.
  • 22
    Tan YY, Fan YG, Lu Y, et al. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J. 2005; 11: 248-253.
  • 23
    van Iterson V, Leidenius M, Krogerus L, von Smitten K. Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat. 2003; 82: 39-45.
  • 24
    Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003; 10: 1140-1151.
  • 25
    Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol. 2006; 32: 29-33.
  • 26
    Wong SL, Edwards MJ, Chao C, et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg. 2001; 136: 563-568.
  • 27
    Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg. 2004; 139: 648-651.
  • 28
    Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003; 10: 248-254.
  • 29
    Lambert LA, Ayers GD, Hwang RF, et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2006; 13: 310-320.
  • 30
    Kocsis L, Svebis M, Boross G, et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg. 2004; 70: 1019-1024.
  • 31
    Soni NK, Carmalt HL, Gillett DJ, Spillane AJ. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol. 2005; 31: 958-964.
  • 32
    Smidt ML, Kuster DM, van der Wilt GJ, Thunnissen FB, Van Zee KJ, Strobbe LJ. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol. 2005; 12: 1066-1072.
  • 33
    Ponzone R, Maggiorotto F, Mariani L, et al. Comparison of 2 models for the prediction of nonsentinel node metastases in breast cancer. Am J Surg. 2007; 193: 686-692.
  • 34
    Dauphine CE, Haukoos JS, Vargas MP, Isaac NM, Khalkhali I, Vargas HI. Evaluation of 3 scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2007; 14: 1014-1019.
  • 35
    Klar M, Jochmann A, Foeldi M, et al. The MSKCC nomogram for prediction of the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat. 2008; 112: 523-531.
  • 36
    Alran S, De Rycke Y, Fourchotte V, et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol. 2007; 14: 2195-2201.
  • 37
    Scow JSDA, Hoskin TL, Reynolds C, Boughey JC. Simple prediction models for breast cancer patients with solitary positive sentinel nodes: are they valid? Breast J. In press.
  • 38
    Kohrt HEOR, Jeffrey SS. Stanford Online Calculator. Available at: https://www3-hrpdcc.stanford.edu/nsln-calculator/ Accessed on May 5, 2008.
  • 39
    DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under 2 or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44: 837-845.
  • 40
    Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons; 2000.
  • 41
    Cripe MH, Beran LC, Liang WC, Sickle-Santanello BJ. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram. Am J Surg. 2006; 192: 484-487.
  • 42
    Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer. 2006; 106: 4-16.
  • 43
    Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006; 98: 599-609.
  • 44
    Zakaria S, Pantvaidya G, Reynolds CA, et al. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different? Surgery. 2008; 143: 641-647.
  • 45
    Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005; 12: 654-659.